DR3

DR3

DR3 Product List

Species
  • Human(4)
  • Cynomolgus(2)
  • Mouse(1)
Tag
  • His Tag(3)
  • Fc Tag(2)
  • Fc Tag & Avi Tag(1)
  • His Tag & Avi Tag(1)
Host
  • HEK293(7)
Conjugate
  • Unconjugated(5)
  • Biotin-labeled(2)
Grade
  • RUO(7)
Low Endotoxin
  • Yes(5)
  • No(2)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&Price
DR3
Human DR3 / TNFRSF25 Protein, His Tag, low endotoxin (Mass Spec & MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISASPRBLI

$375.00

100ug
DR3
Human DR3 Protein, Fc Tag, low endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISASPR

$355.00

100ug
DR3
HOTAvitag
DR3-H82E3
Biotinylated Human DR3 / TNFRSF25 Protein, His,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISASPR

$400.00

25ug
DR3
Cynomolgus DR3 / TNFRSF25 Protein, His Tag, low endotoxin (SPR verified)
Cynomolgus
HEK293
SDS-PAGE
SPR

$355.00

100ug
DR3
Avitag
DR3-H82F3
Biotinylated Human DR3 / TNFRSF25 Protein, Fc,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISASPR

$415.00

25ug
DR3
Mouse DR3 / TNFRSF25 Protein, His Tag, low endotoxin (HPLC & SPR verified)
Mouse
HEK293
HPLCSDS-PAGE
SPR

$355.00

100ug
DR3
Cynomolgus DR3 / TNFRSF25 Protein, Fc Tag, low endotoxin
Cynomolgus
HEK293
SDS-PAGE

$355.00

100ug
You Have Viewed 1-7 Of 7 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
OntamalimabSHP-647; PF-00547659; PF-547659Phase 3 ClinicalPfizer Inc
Ileitis; Colitis, Ulcerative; Crohn Disease
Details
Vedolizumab biosimilar (Polpharma Biologics)PB-016Phase 3 ClinicalPolpharma Biologics Sa
Pouchitis; Colitis, Ulcerative; Crohn Disease
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
VedolizumabMLN-0002; LPD-02; MLN-002; MLN-02; LDP-02ApprovedMillennium Pharmaceuticals Inc安吉优, EntyvioUnited StatesColitis, Ulcerative; Crohn DiseaseTakeda Pharmaceuticals USA Inc2014-05-20
Celiac Disease; Carcinoma, Non-Small-Cell Lung; Melanoma; Crohn Disease; Gastritis; Urogenital Neoplasms; Colitis, Ulcerative; Cholangitis, Sclerosing; Pediatric ulcerative colitis; Solid tumours; Colitis; Pouchitis; Neoplasms; Pediatric Crohn's disease; Inflammatory Bowel Diseases; HIV Infections; Hematopoietic stem cell transplantation (HSCT)
Details
Customer Reviews